PEYE - PEYE STOCK NEWS

Precision Optics Corporation (OTCQB: PEYE) announced preliminary revenue for the fourth quarter and fiscal year ended June 30, 2021. Fiscal 2021 revenue is projected at $10.6 - $10.7 million, marking an 8% increase from the previous year, driven by enhanced production capabilities despite pandemic impacts. Q4 revenue estimates are $2.6 - $2.7 million, up 16-21% year-over-year and 6-10% sequentially. Cash balance rose to $850,000. CEO Joseph Forkey expressed optimism about continued growth in fiscal 2022, supported by a robust engineering pipeline.

Precision Optics Corporation (OTCQB: PEYE) reported its third-quarter results for the fiscal year ending March 31, 2021, with revenue of $2.46 million, up from $2.37 million year-over-year. The net income reached $552,280, attributed partly to the forgiveness of the SBA PPP Loan. Despite a slight decline in gross margins at 33%, the company maintains a strong cash position of $782,000. CEO Joseph Forkey highlighted a robust market for micro-optic devices, with an expected increase in production levels and engineering projects moving into production as key growth drivers.

Precision Optics Corporation (OTCQB: PEYE) has announced a conference call to discuss its third quarter fiscal year 2021 financial results, scheduled for May 13, 2021, at 5:00pm ET. The Company plans to release its financial results and file its 10-Q after market close on the same day. Interested parties can join the call by dialing (844) 735-3662 or via a live webcast. Precision Optics focuses on providing advanced micro-optics and 3D imaging technologies for the healthcare and defense/aerospace sectors, enhancing surgical imaging systems and meeting complex customer requirements.

Precision Optics Corporation (OTCQB: PEYE), based in Gardner, Massachusetts, is set to present at the Lytham Partners Spring 2021 Investor Conference on March 30, 2021, at 11:00 AM ET. A webcast of the presentation will be available on the company's website and archived for later viewing. The event will also include virtual one-on-one meetings from March 30 to April 1, 2021. Founded in 1982, Precision Optics specializes in advanced optical instruments for medical and defense applications. For more information, visit www.poci.com.

Precision Optics Corporation (OTCQB: PEYE) reported its second quarter fiscal 2021 results, revealing revenue of $2.79 million, nearly unchanged from the prior year's $2.80 million. Gross margins declined to 31% from 33% year-over-year. The company recorded a net loss of $213,000, significantly reduced from a loss of $551,000 in the previous year. Despite challenges from COVID-19 affecting production, there is optimism for an uptick in demand as restrictions ease. Engineering revenue for the first half of fiscal 2021 surpassed the total for fiscal 2020.

Precision Optics Corporation (OTCQB: PEYE) has announced a conference call to discuss its second quarter fiscal year 2021 financial results, scheduled for February 16, 2021, at 5:00 PM ET. The financial results and the 10-Q filing will be released after market close on the same day. Interested parties can join via phone or a live webcast. The company is known for developing advanced optical instruments and believes its innovative technologies present significant opportunities in medical applications.

Precision Optics Corporation (OTCQB: PEYE) will participate in the Lytham Partners Virtual Investor Conference on October 7, 2020, at 2:00 PM ET. The presentation will be available via webcast on the company's investor relations page, with a replay offered post-event. Management will also hold one-on-one meetings. Founded in 1982, Precision Optics specializes in advanced optical instruments for medical applications, focusing on minimally invasive surgery and diagnostics. The company's innovative offerings include Microprecision micro-optics and endoscopes.

Precision Optics Corporation (OTCQB: PEYE) announced its fourth quarter and fiscal year 2020 results, reporting a quarterly revenue of $2.24 million, down 6% from $2.38 million year-over-year, primarily due to COVID-19 impacts. For the fiscal year, revenue rose by 46% to $9.9 million, attributed to the full-year contribution from Ross Optical. The company experienced a net loss of $323,085 for Q4 and $1,426,150 for the fiscal year. Gross margins were 29% for Q4 and 34% for the fiscal year. The company remains optimistic about future revenue improvements following COVID-related disruptions.

Precision Optics Corporation (OTCQB: PEYE) announced its fourth quarter and fiscal year 2020 conference call scheduled for September 24, 2020, at 5:00 pm ET. The Company will release its financial results and file its 10-K after market close on the same day. Interested parties can access the call via phone or a live Internet webcast. A replay will be available until October 1, 2020. The Company specializes in advanced optical instruments and is known for its innovative medical devices.